We are a development-stage medical technology company headquartered in San Diego, California. Our focus is the creation of therapeutic solutions that overcome current limitations in healthcare.
Our candidate solutions include: the ImmunePrep™ platform to enhance the activity of antibody-based immunotherapies, ChemoPrep™ to improve the delivery of cancer chemotherapies, ChemoPure™ to reduce the post-treatment toxicity of chemotherapy, and Sigyn Therapy™ to treat pathogen-associated inflammatory disorders that are not addressed with drug therapies.